TY - JOUR
T1 - Current Status of Next-Generation Sequencing Approaches for Candidate Gene Discovery in Familial Parkinson´s Disease
AU - Pillay, Nikita Simone
AU - Ross, Owen A.
AU - Christoffels, Alan
AU - Bardien, Soraya
N1 - Funding Information:
NSP is supported by South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa (award number UID 64751); OAR is supported by grants from NIH/NINDS (U54-NS100693, UG3-NS104095, U54-NS110435), Department of Defense (DOD) (W81XWH-17-1-0249), The Michael J. Fox Foundation and American Parkinson disease Association Center for Advanced Research; AC is supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa (award number UID 64751); SB is supported by grants from the South African Medical Research Council (Self-Initiated Research Grant) and the National Research Foundation of South Africa (Grant Numbers: 106052 and 129249).
Funding Information:
We acknowledge the support of the DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Publisher Copyright:
Copyright © 2022 Pillay, Ross, Christoffels and Bardien.
PY - 2022/3/1
Y1 - 2022/3/1
N2 - Parkinson’s disease is a neurodegenerative disorder with a heterogeneous genetic etiology. The advent of next-generation sequencing (NGS) technologies has aided novel gene discovery in several complex diseases, including PD. This Perspective article aimed to explore the use of NGS approaches to identify novel loci in familial PD, and to consider their current relevance. A total of 17 studies, spanning various populations (including Asian, Middle Eastern and European ancestry), were identified. All the studies used whole-exome sequencing (WES), with only one study incorporating both WES and whole-genome sequencing. It is worth noting how additional genetic analyses (including linkage analysis, haplotyping and homozygosity mapping) were incorporated to enhance the efficacy of some studies. Also, the use of consanguineous families and the specific search for de novo mutations appeared to facilitate the finding of causal mutations. Across the studies, similarities and differences in downstream analysis methods and the types of bioinformatic tools used, were observed. Although these studies serve as a practical guide for novel gene discovery in familial PD, these approaches have not significantly resolved the “missing heritability” of PD. We speculate that what is needed is the use of third-generation sequencing technologies to identify complex genomic rearrangements and new sequence variation, missed with existing methods. Additionally, the study of ancestrally diverse populations (in particular those of Black African ancestry), with the concomitant optimization and tailoring of sequencing and analytic workflows to these populations, are critical. Only then, will this pave the way for exciting new discoveries in the field.
AB - Parkinson’s disease is a neurodegenerative disorder with a heterogeneous genetic etiology. The advent of next-generation sequencing (NGS) technologies has aided novel gene discovery in several complex diseases, including PD. This Perspective article aimed to explore the use of NGS approaches to identify novel loci in familial PD, and to consider their current relevance. A total of 17 studies, spanning various populations (including Asian, Middle Eastern and European ancestry), were identified. All the studies used whole-exome sequencing (WES), with only one study incorporating both WES and whole-genome sequencing. It is worth noting how additional genetic analyses (including linkage analysis, haplotyping and homozygosity mapping) were incorporated to enhance the efficacy of some studies. Also, the use of consanguineous families and the specific search for de novo mutations appeared to facilitate the finding of causal mutations. Across the studies, similarities and differences in downstream analysis methods and the types of bioinformatic tools used, were observed. Although these studies serve as a practical guide for novel gene discovery in familial PD, these approaches have not significantly resolved the “missing heritability” of PD. We speculate that what is needed is the use of third-generation sequencing technologies to identify complex genomic rearrangements and new sequence variation, missed with existing methods. Additionally, the study of ancestrally diverse populations (in particular those of Black African ancestry), with the concomitant optimization and tailoring of sequencing and analytic workflows to these populations, are critical. Only then, will this pave the way for exciting new discoveries in the field.
KW - Parkinson’s disease
KW - african ancestry
KW - bioinformatic pipelines
KW - diverse populations
KW - familial PD
KW - next-generation sequencing
KW - third-generation sequencing
KW - whole-exome sequencing
UR - http://www.scopus.com/inward/record.url?scp=85127353365&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127353365&partnerID=8YFLogxK
U2 - 10.3389/fgene.2022.781816
DO - 10.3389/fgene.2022.781816
M3 - Article
AN - SCOPUS:85127353365
VL - 13
JO - Frontiers in Genetics
JF - Frontiers in Genetics
SN - 1664-8021
M1 - 781816
ER -